Press release
EuroPriSe: vbl.de first website awarded with European Privacy Seal
VBL. Versorgungsanstalt des Bundes und der Länder (Pension Institution of the Federal Republic and the Länder) has successfully completed the first trial run of the new EuroPriSe “Website Certification” process.EuroPriSe’s Website Certification certifies that data processing resulting from typical interactions between a web server and the visitor’s browser conforms to European data protection law. Central aspects of the certification process include the usage of cookies, the storage of IP addresses, and the availability of complete and intelligible information for website visitors in the legal notice, privacy policy, and cookie policy. Web-based services, such as those offered by an online shop, and access-restricted areas (such as “My VBL” in this case) are not covered by the certification.
EuroPriSe will further develop its new “Website Certification” on the basis of experiences gathered during its trial run with the goal of reducing the cost and length of the process using concrete requirements and best-practice recommendations, as well as tools to automate examination processes (e.g. “online audits”), without negatively affecting the high quality of the certification. Initial progress in the development process will be presented on November 6th, 2015, at the next EuroPriSe Expert Enhancement Workshop in Berlin.
“The VBL took on the special challenges of running a pilot process and handled them with confidence and professionalism,” says Sebastian Meissner, Head of the EuroPriSe Certification Authority. “The notification system for the usage of cookies is particularly exemplary, efficiently combining a cookie banner and Cookie Policy web page to keep visitors informed.”
Further information on the certification of www.vbl.de can be found at https://www.european-privacy-seal.eu/EPS-en/VBL-wwwvblde.
About EuroPriSe
EuroPriSe started as an EU-funded project aimed at establishing a trans-European privacy seal. Today, EuroPriSe offers certifications for IT products and IT-based services throughout the EU. A unique certification, the EuroPriSe seal assures users that their personal data are handled in accordance with European data protection laws. As the only EU-wide, independent privacy seal, EuroPriSe enables enterprises to demonstrate their compliance with European laws and regulations. EuroPriSe certifications have been awarded to businesses of all sizes, including small and medium-sized companies as well as multinational organizations such as Microsoft and SAP.
About VBL (Pension Institution of the Federal Republic and the Länder)
The Versorgungsanstalt des Bundes und der Länder (VBL) has been providing public-sector occupational pensions for over 85 years. It is the largest provider of supplementary pensions in Germany. Occupational pensions are based on the collective labour agreements negotiated between employers and the unions. Currently about 4.4 million insured employees use VBL’s services. More than 1.2 million pensioners receive a supplementary pension from VBL alongside their state pension.
Press Contact:
Sebastian Meissner
EuroPriSe GmbH
Joseph-Schumpeter-Allee 25, 53227 Bonn, Germany
Email: contact@european-privacy-seal.eu
Phone: +49 228 763 679 30
www.european-privacy-seal.eu
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release EuroPriSe: vbl.de first website awarded with European Privacy Seal here
News-ID: 316304 • Views: …
More Releases from EuroPriSe GmbH

EuroPriSe celebrates 10th anniversary and looks forward to acting as an accredit …
The idea of a European Privacy Seal assumed shape in 2004 when trust and accountability increasingly became factors and data protection their essential conveyor. EuroPriSe was first introduced as an EU-funded project. The EuroPriSe project phase lasted from 2007 until 2009. During that period, a general framework for the European Privacy Seal was established and is essentially valid until today. Three data protection authorities (DPAs) took part in the…

EuroPriSe: GDPR ready certification criteria for products and services to be ope …
In spring 2016, the entry into force of the General Data Protection Regulation (GDPR) which will be applicable from late May 2018 required EuroPriSe to initiate an update of its certification criteria. The major objective of this update was to incorporate the new legal provisions that are introduced by the regulation into the existing certification catalogue. At the same time, EuroPriSe Certification Authority (CA) took the opportunity to adjust this…

EuroPriSe: Privacy-friendly Internet search with Ixquick and Startpage reaffirme …
Netherlands based Surfboard Holding B.V. proved that their meta search engines Ixquick and Startpage still meet all relevant requirements of EU data protection law.
Surfboard Holding B.V. runs a meta search engine which is provided under two different names: Ixquick and Startpage. Both versions of the service use the same IT-systems, but a different look and feel. Users can search the Internet for web pages, images and videos, therefore making use…
More Releases for VBL
Glioblastoma Multiforme Treatment Market Size Report 2034 | Genentech, Merck, Da …
DelveInsight's "Glioblastoma Multiforme Market Insight, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of GBM, historical and forecasted epidemiology as well as the GBM market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Discover Key Insights into the Glioblastoma Multiforme Market with DelveInsight's In-Depth Report @ Glioblastoma Multiforme Market Size- https://www.delveinsight.com/sample-request/glioblastoma-multiforme-gbm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Glioblastoma Multiforme Market Report
• In February 2025:-…
Glioblastoma Multiforme Drugs Market Size 2032 | Genentech, Merck, Daiichi Sanky …
DelveInsight's 'Glioblastoma Multiforme Market Insights, Epidemiology and Market Forecast- 2032' report delivers an in-depth understanding of the Glioblastoma Multiforme, historical and forecasted epidemiology as well as the Glioblastoma Multiforme market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Key Takeaways from the Glioblastoma Multiforme Market Report
• July 2024:- VBI Vaccines Inc.:- A Three-part, Phase I/II Dose-Escalation Study to Define the Safety, Tolerability, and Optimal…
Glioblastoma Multiforme Pipeline Insights 2024 | Clinical Trials, Latest Approva …
As per DelveInsight's assessment, about 100+ key pharma and biotech companies are working on 100+ pipeline drugs in the Glioblastoma Multiforme therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.
The expected launch of potential therapies may increase the Glioblastoma Multiforme market size…
COVID-19 Competitive Landscape (Updated) | Westvac Biopharma, Xenothera, Windtre …
DelveInsight's, "COVID-19 Competitive Landscape" report provides comprehensive insights about 400+ COVID-19 Companies and 500+ drugs in Covid-19 Competitive landscape. It covers the COVID-19 therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the COVID-19 Report
• DelveInsight's COVID-19 report depicts a robust space with 400+ active players working to develop 500+ pipeline therapies for COVID-19 treatment.
• The…
Recurrent Glioblastoma Market to Grow Positively at a Paltry CAGR | Companies- A …
(New York, Nevada, Las Vegas), DelveInsight's "Recurrent Glioblastoma - Market Insight, Epidemiology and Market Forecast - 2032" report provides current treatment practices, emerging drugs, Recurrent Glioblastoma market share of the individual therapies, current and forecasted Recurrent Glioblastoma market size from 2019 to 2032 segmented by seven major markets. The report also offers current Recurrent Glioblastoma therapy algorithms, market drivers, market barriers, and unmet medical needs to curate the best of…
Gene Therapies for Cancer Treatment Market Insights and Global Outlook During 20 …
The Gene Therapies for Cancer Treatment Market recently Published a global Market research study with more than 100 industry informative desk and Figures spread through Pages and easy to understand detailed TOC on “Gene Therapies for Cancer Treatment Market”.
The report provides information and the advancing business series information in the sector to the exchange. The report provides a notion connected to the progress of this market movement of significant players…